These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3499543)

  • 21. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases.
    Worman CP; Catovsky D; Cawley JC; Bevan PC; Bottomley JM; Nethersell AB
    Leukemia; 1987 Apr; 1(4):320-2. PubMed ID: 3669754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
    Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
    Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A; Berman E; Black P; Koziner B
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of immune functions by long-term treatment with recombinant interferon-alpha 2 in a patient with hairy-cell leukemia.
    Teichmann JV; Sieber G; Ludwig WD; Ruehl H
    J Interferon Res; 1988 Feb; 8(1):15-24. PubMed ID: 3259251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
    Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of hairy-cell leukemia using interferon alfa].
    Neuwirtová R; Cermák J; Kvasnicka J; Sedlácková M
    Cas Lek Cesk; 1989 Aug; 128(34):1065-70. PubMed ID: 2790914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
    Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients.
    Schwarzinger I; Bettelheim P; Chott A; Herold C; Hinterberger W; Köller U; Kos M; Neumann E; Radaszkiewicz T; Lechner K
    Wien Klin Wochenschr; 1988 Jan; 100(2):47-51. PubMed ID: 3348041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia.
    Gibson J; Gallagher K; Cameron K; Basten A; Gatenby P; Joshua D; Kronenberg H
    Aust N Z J Med; 1988 Dec; 18(7):897-9. PubMed ID: 3074762
    [No Abstract]   [Full Text] [Related]  

  • 34. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT; Mold NG
    Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid improvement in a terminal case of hairy cell leukemia treated with a new human recombinant interferon, IFN-alpha-C.
    Aderka D; Levo Y; Rahmani R; Mory Y; Vaks B; Horowitz O; Doerner T; Shoham J; Wallach D; Revel M
    Isr J Med Sci; 1985 Dec; 21(12):977-81. PubMed ID: 4093298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
    Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic effect of interferon-alpha on hairy cell leukemia].
    Abe Y; Sakai K; Igarashi T; Ishibashi T; Shiga T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Apr; 30(4):535-40. PubMed ID: 2769975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.